Piramal Pharma Limited

NSE: PPLPHARMA BSE: PPLPHARMA

NSE

220.76 0.35 (0.16%)

Prev Close

220.41

Open Price

221.9

Volume

3,206,567

Today Low / High

217.95 / 222.4

52 WK Low / High

136.1 / 307.9

Range

210 - 232

BSE

220.80 0.65 (0.30%)

Prev Close

220.15

Open Price

223.15

Volume

137,036

Today Low / High

218 / 223.15

52 WK Low / High

135.85 / 307.85

Range

210 - 232

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 220.76 (target range: 210 - 232), reflecting a change of 0.35 (0.15879%). On the BSE, it is listed at 220.8 (target range: 210 - 232), showing a change of 0.65 (0.29525%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

21 Apr 221.90 -0.51%

17 Apr 221.79 -0.62%

16 Apr 223.00 -0.52%

15 Apr 224.00 -0.66%

11 Apr 216.67 1.46%

09 Apr 221.50 -5.93%

08 Apr 224.25 -1.20%

07 Apr 187.30 15.80%

04 Apr 229.00 -2.92%

03 Apr 234.40 -1.83%

02 Apr 226.10 0.84%

01 Apr 224.00 0.68%

28 Mar 219.93 2.19%

27 Mar 218.80 0.00%

26 Mar 226.72 -3.41%

25 Mar 221.59 2.32%

24 Mar 229.00 -4.35%

Piramal Pharma Limited Graph

If you are looking for the target price for Piramal Pharma Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 220.76, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario	Price	Target	Range
Bullish Scenario	220.80	223.01	200.71 - 245.31
		225.22	180.17 - 270.26
		227.42	159.20 - 295.65
Bearish Scenario	220.80	218.59	196.73 - 240.45
		216.38	173.11 - 259.66
		214.18	149.92 - 278.43

ISIN

INE0DK501011

Industry

Biotechnology

Vol.Avg

7,860,799

Market Cap

292,672,172,632

Last Dividend

0.11

Official Website

Visit Website

IPO Date

2022-10-19

DCF Diff

389.08

DCF

-181

Financial Ratios Every Investor Needs

Stock Dividend of PPLPHARMA

Date	Label	Adj Dividend	Dividend	Record Date	Payment Date	Declaration Date
2024-07-12	July 12, 24	0.11	0.11	2024-07-12	2024-08-25

Stock Rating Details for PPLPHARMA

Metric	Value	Recommendation
Overall Rating	D+	Strong Sell
DCF Score	1	Strong Sell
ROE Score	1	Strong Sell
ROA Score	1	Strong Sell
Debt-to-Equity (DE) Score	1	Strong Sell
Price-to-Earnings (PE) Score	1	Strong Sell
Price-to-Book (PB) Score	1	Strong Sell

Annual Financial Income Report

Date	Revenue	Co.Rev	GP	GPR	R&D Expenses	G&A Expenses	Operating Income	Net Income	EPS	EBITDA	NIR
2024-03-31	8,171.16 Cr	3,261.71 Cr	4,909.45 Cr	0.6008	100.67 Cr	262.75 Cr	431.51 Cr	17.82 Cr	0.14	1,366.81 Cr	0.0022
2023-03-31	7,081.55 Cr	3,000.18 Cr	4,081.37 Cr	0.5763	86.36 Cr	231.69 Cr	-47.97 Cr	-186.46 Cr	-1.54	846.35 Cr	-0.0263
2022-03-31	6,471.50 Cr	2,680.31 Cr	3,791.19 Cr	0.5858	128.34 Cr	191.21 Cr	365.16 Cr	375.96 Cr	3.09	1,259.94 Cr	0.0581
2021-03-31	2,899.75 Cr	1,254.03 Cr	1,645.72 Cr	0.5675	69.14 Cr	53.85 Cr	480.53 Cr	571.50 Cr	4.70	611.35 Cr	0.1971

Annual Financials Balance Sheet

Date	C&C Equ.	Tot. Assets	Tot. Liab.	Stock. Equity	Tot. Debt	Net Debt	Inv.	PP&E (Net)	Curr. Def. Rev.	Non-Curr. Def. Rev.	LT Invest.	Curr. Liab.
2024-03-31	356.82 Cr	15,311.81 Cr	7,400.44 Cr	7,911.3700 Cr	4,710.16 Cr	4,353.34 Cr	2,175.88 Cr	4,815.96 Cr	343.62 Cr	0.00 Cr	240.26 Cr	4,369.3000 Cr
2023-03-31	195.59 Cr	14,522.56 Cr	7,749.06 Cr	6,773.5000 Cr	5,637.08 Cr	5,441.49 Cr	1,681.37 Cr	4,441.44 Cr	201.13 Cr	175.58 Cr	211.87 Cr	3,843.0500 Cr
2022-03-31	228.10 Cr	12,797.04 Cr	6,100.44 Cr	6,696.6000 Cr	4,127.92 Cr	3,899.82 Cr	1,388.80 Cr	3,715.74 Cr	185.19 Cr	0.00 Cr	216.77 Cr	3,033.3400 Cr
2021-03-31	146.73 Cr	5,756.67 Cr	1,656.05 Cr	4,100.6200 Cr	174.26 Cr	27.53 Cr	420.88 Cr	1,384.57 Cr	0.00 Cr	0.00 Cr	1,575.88 Cr	1,471.6700 Cr

Annual Financials Cash Flow Statement

Date	Operating Cash	Investing Cash	Financing Cash	Free Cash	Cash Change	Cash at End	CapEx	Income	Debt Repay	Dividends	Inventory
2024-03-31	1,004.5400 Cr	-456.0600 Cr	-422.3600 Cr	292.5000 Cr	165.9600 Cr	219.1900 Cr	-712.0400 Cr	17.8200 Cr	-971.5300 Cr	0.0000 Cr	-531.7500 Cr
2023-03-31	483.8900 Cr	-1,338.7800 Cr	817.7900 Cr	-480.8600 Cr	-31.9500 Cr	53.2300 Cr	-964.7500 Cr	-160.5600 Cr	1,198.4200 Cr	-67.0000 Cr	-172.6400 Cr
2022-03-31	766.4200 Cr	-1,812.1000 Cr	905.7400 Cr	-123.0900 Cr	85.1800 Cr	85.1800 Cr	-889.5100 Cr	436.7000 Cr	1,019.1300 Cr	-50.0000 Cr	-60.3300 Cr
2021-03-31	34.7200 Cr	-4,382.8900 Cr	4,494.1600 Cr	-23.3900 Cr	145.9900 Cr	146.7300 Cr	-58.1100 Cr	349.1100 Cr	90.3800 Cr	0.0000 Cr	95.3600 Cr

Quarterly Financial Income Report

Date	Revenue	Co.Rev	GP	GPR	Operating Income	Net Income	EPS	EBITDA	NIR
2024-12-31	2,204.22 Cr	805.83 Cr	1,398.39 Cr	0.6344	140.93 Cr	3.68 Cr	0.03	366.92 Cr	0.0017
2024-09-30	2,241.75 Cr	1,548.22 Cr	693.53 Cr	0.3094	149.39 Cr	22.59 Cr	0.17	402.72 Cr	0.0101
2024-06-30	1,951.14 Cr	1,438.61 Cr	512.53 Cr	0.2627	19.94 Cr	-88.64 Cr	-0.67	224.03 Cr	-0.0454
2024-03-31	2,552.36 Cr	1,704.67 Cr	847.69 Cr	0.3321	333.80 Cr	101.27 Cr	0.77	536.29 Cr	0.0397
2023-12-31	1,958.57 Cr	675.15 Cr	1,283.42 Cr	0.6553	82.05 Cr	10.11 Cr	0.08	297.61 Cr	0.0052

Quarterly Financials Balance Sheet

Date	Cash & Equiv.	Short-Term Inv.	Cash & Short-Term	Net Receivables	Inventory	Total Curr. Assets	PP&E (Net)	Total Assets	Total Liabilities
2024-09-30	270.30 Cr	182.48 Cr	452.78 Cr	1,827.14 Cr	2,447.43 Cr	5,381.66 Cr	4,918.75 Cr	15,241.74 Cr	7,334.57 Cr
2024-06-30	-501.51 Cr	1,003.02 Cr	501.51 Cr	0.00 Cr	0.00 Cr	501.51 Cr	0.00 Cr	0.00 Cr	-7,911.37 Cr
2024-03-31	356.82 Cr	144.69 Cr	503.53 Cr	2,134.80 Cr	2,175.88 Cr	5,464.47 Cr	4,815.96 Cr	15,311.81 Cr	7,400.44 Cr
2023-12-31	-595.12 Cr	1,190.24 Cr	595.12 Cr	0.00 Cr	0.00 Cr	595.12 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2023-09-30	251.50 Cr	413.81 Cr	665.31 Cr	1,743.38 Cr	2,060.47 Cr	4,954.02 Cr	4,691.26 Cr	14,775.69 Cr	7,017.83 Cr

Quarterly Financials Cash Flow Statement

Date	Net Income	Operating Cash Flow	Net Cash Change	Cash at End	Cash at Beginning	Free Cash Flow
2024-06-30	-88.64 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2024-03-31	101.27 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2023-12-31	10.11 Cr	372.64 Cr	372.64 Cr	908.62 Cr	535.98 Cr	372.64 Cr
2023-09-30	5.02 Cr	369.02 Cr	369.02 Cr	535.98 Cr	166.96 Cr	369.02 Cr
2023-06-30	-98.58 Cr	347.22 Cr	597.79 Cr	651.02 Cr	53.23 Cr	347.22 Cr

Splits History

Date	Label	Split Ratio
2023-08-02	August 02, 23	1023:1000

Similar Stocks: Biotechnology

Company Name	Symbol	Price	Market Cap	Volume
Biocon Limited	BIOCON	₹331.90	₹398,479,140,000.00	₹1,860,996.00
Piramal Pharma Limited	PPLPHARMA	₹220.76	₹292,672,172,632.00	₹3,206,567.00
Syngene International Limited	SYNGENE	₹724.60	₹290,777,127,354.00	₹309,960.00
Concord Biotech Limited	CONCORDBIO	₹1,712.30	₹179,134,319,260.00	₹167,947.00
Blue Jet Healthcare Limited	BLUEJET	₹742.40	₹128,780,727,808.00	₹402,801.00
Jubilant Ingrevia Limited	JUBLINGREA	₹674.95	₹107,506,805,443.00	₹165,388.00
Supriya Lifescience Limited	SUPRIYA	₹743.80	₹59,863,106,640.00	₹485,094.00
Dishman Carbogen Amcis Limited	DCAL	₹210.73	₹33,038,902,663.00	₹169,506.00
Panacea Biotec Limited	PANACEABIO	₹504.80	₹30,919,375,571.00	₹556,110.00
Zota Health Care Limited	ZOTA	₹884.35	₹24,657,917,174.00	₹61,116.00

Key Executives

President, Chief Financial Officer & Executive Whole-Time Director

Mr. Vivek Valsaraj

Gender: male

Year Born: 1973

Senior Vice President of Operations

Vinay Agarwal

Gender: Not Specified

Year Born: 1964

Vice President of Marketing

Sameer Penkar

Gender: Not Specified

Year Born:

Executive Vice President of India & UK Formulations

Mr. Debashish Chakravorty

Gender: male

Year Born: 1967

Company Secretary & Compliance Officer

Ms. Tanya Sanish

Gender: female

Year Born:

Head of Investor Relations & Sustainability

Mr. Gagan Borana

Gender: male

Year Born:

Senior Vice President of Human Resources

Mr. Vikram Duggal

Gender: male

Year Born: 1975

Chief Executive Officer of Piramal Global Pharma & Director

Mr. Peter Daniel DeYoung

Gender: male

Year Born: 1978

Vice President of Sales

Prashanth M. S.

Gender: Not Specified

Year Born: 1973

Executive Chairperson

Ms. Nandini Ajay Piramal

Gender: female

Year Born: 1980

FAQs about Piramal Pharma Limited

Who is the CEO of the company?

The CEO is Mr. Peter Daniel DeYoung.

What is the current market price of the stock?

The current price is ₹220.76.

What is the 52-week price range?

The range is ₹136.1-307.9.

What is the market capitalization of the company?

The market capitalization is ₹29,267.22 crores.

What is the dividend yield?

The dividend yield is 0.05%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 696.14.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Piramal Pharma Limited (ISIN: INE0DK501011) is a leading Biotechnology in India. With a market capitalization of ₹29,267.22 crores and an average daily volume of 7,860,799 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.11.

Piramal Pharma Limited

Piramal Pharma Limited Graph

Piramal Pharma Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

Overview of Piramal Pharma Limited

Financial Ratios Every Investor Needs

Stock Dividend of PPLPHARMA

Stock Rating Details for PPLPHARMA

Annual Financial Income Report

Annual Financials Balance Sheet

Annual Financials Cash Flow Statement

Quarterly Financial Income Report

Quarterly Financials Balance Sheet

Quarterly Financials Cash Flow Statement

Splits History

Similar Stocks: Biotechnology

Key Executives

FAQs about Piramal Pharma Limited

QUICK LINKS

STAY CONNECTED